Skip to main content

Mi-Omega Side Effects

Generic name: omega-3 polyunsaturated fatty acids

Medically reviewed by Drugs.com. Last updated on Jan 4, 2023.

Note: This document contains side effect information about omega-3 polyunsaturated fatty acids. Some dosage forms listed on this page may not apply to the brand name Mi-Omega.

Applies to omega-3 polyunsaturated fatty acids: oral capsule liquid filled.

Serious side effects of Mi-Omega

Along with its needed effects, omega-3 polyunsaturated fatty acids (the active ingredient contained in Mi-Omega) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking omega-3 polyunsaturated fatty acids:

Incidence not known

Other side effects of Mi-Omega

Some side effects of omega-3 polyunsaturated fatty acids may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

  • Acid or sour stomach
  • bad, unusual, or unpleasant (after) taste
  • belching
  • bloated or full feeling
  • change in taste
  • excess air or gas in the stomach
  • heartburn
  • indigestion
  • stomach discomfort, upset, or pain

Incidence not known

  • Diarrhea
  • difficulty having a bowel movement (stool)
  • loss of appetite
  • nausea or vomiting
  • passing of gas
  • stomach fullness

For Healthcare Professionals

Applies to omega-3 polyunsaturated fatty acids: oral capsule, oral delayed release capsule, oral kit, oral liquid, oral tablet chewable.

Gastrointestinal

Common (1% to 10%): Eructation, dyspepsia, nausea, gastrointestinal disorders (including abdominal distension, abdominal pain, constipation, diarrhea, flatulence, gastroesophageal reflux disease, vomiting)

Uncommon (0.1% to 1%): Gastrointestinal hemorrhage, gastroenteritis

Rare (less than 0.1%): Gastrointestinal pain

Very rare (less than 0.01%): Lower gastrointestinal hemorrhage[Ref]

General

The most common adverse events were eructation, dyspepsia, and taste perversion[Ref]

Other

Common (1% to 10%): Infection, pain

Uncommon (0.1% to 1%): Death[Ref]

Dermatologic

Common (1% to 10%): Rash

Uncommon (0.1% to 1%): Atopic dermatitis

Rare (less than 0.1%): Urticaria, acne, rash pruritic

Frequency not reported: Pruritus[Ref]

Cardiovascular

Uncommon (0.1% to 1%): Hypotension[Ref]

Musculoskeletal

Common (1% to 10%): Back pain[Ref]

Metabolic

Uncommon (0.1% to 1%): Hyperglycemia, gout, high triglycerides

Very rare (less than 0.01%): Blood lactate dehydrogenase increased[Ref]

Nervous system

Common (1% to 10%): Taste perversion

Uncommon (0.1% to 1%): Dizziness, dysgeusia, headache, hyperactivity[Ref]

Respiratory

Uncommon (0.1% to 1%): Epistaxis

Very rare (less than 0.01%): Nasal dryness

Frequency not reported: Influenza[Ref]

Hypersensitivity

Rare (less than 0.1%): Hypersensitivity

Postmarketing reports: Anaphylactic reaction[Ref]

Hematologic

Very rare (less than 0.01%): White blood count increased,

Frequency not reported: Slight prolongation of bleeding time

Postmarketing reports: Hemorrhagic diathesis[Ref]

Psychiatric

Uncommon (0.1% to 1%): Tics, tantrum, insomnia[Ref]

Hepatic

Rare (less than 0.1%): Liver disorders (including increased ALT, increased AST, and transaminases increased)[Ref]

Frequently asked questions

References

1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

2. Cerner Multum, Inc. "Australian Product Information." O 0

3. "Product Information. Lovaza (omega-3 polyunsaturated fatty acids)." GlaxoSmithKline (2012):

4. "Product Information. Vayarin (omega-3 polyunsaturated fatty acids)." Vaya Pharma (2017):

5. "Product Information. Omega-3-Acid Ethyl Esters (omega-3 polyunsaturated fatty acids)." Apotex Corporation (2017):

6. "Product Information. Omega-3 D-3 Wellness Pack (omega-3 polyunsaturated fatty acids)." TMIG Inc (2017):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.